Filing Details
- Accession Number:
- 0001628280-24-031167
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-03 17:02:37
- Reporting Period:
- 2024-07-01
- Accepted Time:
- 2024-07-03 17:02:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
834365 | Biolife Solutions Inc | BLFS | Electromedical & Electrotherapeutic Apparatus (3845) | 943076866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1837756 | Sarah Aebersold | 3303 Monte Villa Parkway Suite 310 Bothell WA 98021 | Chief Human Resources Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-07-01 | 3,000 | $21.03 | 61,683 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-15-2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.72 to $21.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.